Supermacroporous Polymer-Based Cryogel Bioreactor for Monoclonal Antibody Production in Continuous Culture Using Hybridoma Cells

被引:25
|
作者
Jain, Era [1 ]
Karande, Anjali A. [2 ]
Kumar, Ashok [1 ]
机构
[1] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India
[2] Indian Inst Sci, Dept Biochem, Bangalore 5600012, Karnataka, India
关键词
antibody production; continuous culture; cryogel bioreactor; hybridoma cells; polymer scaffolds; BIOMEDICAL APPLICATIONS; SUSPENSION-CULTURE; MAMMALIAN-CELLS; GROWTH; KINETICS; MATRICES; METABOLISM; BIOPROCESS; APOPTOSIS; HYDROGELS;
D O I
10.1002/btpr.497
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cryogel matrices composed of different polymeric blends were synthesized, yielding a unique combination of hydrophilicity and hydrophobicity with the presence or absence of charged surface. Four such cryogel matrices composed of polyacrylamide-chitosan (PAAC), poly(N-isopropylacrylamide)-chitosan, polyacrylonitrile (PAN), and poly(N-isopropylacrylamide) were tested for growth of different hybridoma cell lines and production of antibody in static culture. All the matrices were capable for the adherence of hybridoma cell lines 6A4D7, B7B10, and H9E10 to the polymeric surfaces as well as for the efficient monoclonal antibody (mAb) production. PAAC proved to be relatively better in terms of both mAb production and cell growth. Further, PAAC cryogel was designed into three different formats, monolith, disks, and beads, and used as packing material for packed-bed bioreactor. Longterm cultivation of 6A4D7 cell line on PAAC cryogel scaffold in all the three formats could be successfully done for a period of 6 weeks under static conditions. Continuous packed-bed bioreactor was setup using 6A4D7 hybridoma cell line in the three reactor formats. The reactors ran continuously for a period of 60 days during which mAb production and metabolism of cells in the bioreactors were monitored periodically. The monolith bioreactor performed most efficiently over a period of 60 days and produced a total of 57.5 mg of antibody in the first 30 days (in 500 mL) with a highest concentration of 115 mu g mL(-1), which is fourfold higher than t-flask culture. The results demonstrate that appropriate chemistry and geometry of the bioreactor matrix for cell growth and immobilization can enhance the reactor productivity. (C) 2010 American Institute of Chemical Engineers Biotechnol. Prog., 27: 170-180, 2011
引用
收藏
页码:170 / 180
页数:11
相关论文
共 50 条
  • [11] A 3-PHASE PATTERN IN GROWTH, MONOCLONAL-ANTIBODY PRODUCTION, AND METABOLITE EXCHANGE IN A HYBRIDOMA BIOREACTOR CULTURE
    BUSHELL, ME
    BELL, SL
    SCOTT, MF
    SNELL, K
    SPIER, RE
    WARDELL, JN
    SANDERS, PG
    BIOTECHNOLOGY AND BIOENGINEERING, 1993, 42 (01) : 133 - 139
  • [12] THE LOSS OF ANTIBODY PRODUCTIVITY IN CONTINUOUS CULTURE OF HYBRIDOMA CELLS
    FRAME, KK
    HU, WS
    BIOTECHNOLOGY AND BIOENGINEERING, 1990, 35 (05) : 469 - 476
  • [13] Production of monoclonal antibodies in the miniPERM™ bioreactor:: comparison with other hybridoma culture methods
    Falkenberg, FW
    RESEARCH IN IMMUNOLOGY, 1998, 149 (06): : 560 - 570
  • [14] Perfusion culture of hybridoma cells for hyperproduction of IgG2a monoclonal antibody in a wave bioreactor-perfusion culture system
    Tang, Ya-Jie
    Ohashi, Ryo
    Hamel, Jean-Francois P.
    BIOTECHNOLOGY PROGRESS, 2007, 23 (01) : 255 - 264
  • [15] CONTINUOUS PRODUCTION OF MONOCLONAL-ANTIBODY BY HYBRIDOMA CELLS IMMOBILIZED IN HARDENED ALGINATE GEL PARTICLES
    HASHIMOTO, K
    SHIRAI, Y
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 613 : 216 - 226
  • [16] Minimizing hollow fiber bioreactor startup lags for hybridoma monoclonal antibody production.
    Lee, YT
    Bowen, BD
    Piret, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U208 - U208
  • [17] Mathematical modeling and analysis of monoclonal antibody production by hybridoma cells
    Zeng, AP
    BIOTECHNOLOGY AND BIOENGINEERING, 1996, 50 (03) : 238 - 247
  • [18] Continuous production of monoclonal antibody in a packed-bed bioreactor
    Golmakany, N
    Rasaee, MJ
    Furouzandeh, M
    Shojaosadati, SA
    Kashanian, S
    Omidfar, K
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2005, 41 : 273 - 278
  • [19] Improvement of monoclonal antibody production in hybridoma cells by dimethyl sulfoxide
    Ling, WLW
    Deng, L
    Lepore, J
    Cutler, C
    Connon-Carlson, S
    Wang, Y
    Voloch, M
    BIOTECHNOLOGY PROGRESS, 2003, 19 (01) : 158 - 162
  • [20] PERFUSION CULTURES OF HYBRIDOMA CELLS FOR MONOCLONAL-ANTIBODY PRODUCTION
    CASTILLO, FJ
    MULLEN, LJ
    THRIFT, JC
    GRANT, BC
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 665 : 72 - 80